GP120 Produits
(Human Immunodeficiency Virus 1 Surface Glycoprotein (HIV-1 gp120))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories GP120 en vedette
GP120 Anticorps
High quality antibodies with extensive validation data.
GP120 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
GP120 recommandé Anticorps
- (1)
- (1)
- (2)
GP120 recommandé Protéines
- (1)
Dernières publications sur nos produits GP120
: "HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G." dans: PLoS pathogens, Vol. 14, Issue 4, pp. e1007010, (2018) (PubMed).: "Enabling electrical biomolecular detection in high ionic concentrations and enhancement of the detection limit thereof by coupling a nanofluidic crystal with reconfigurable ion concentration ..." dans: Lab on a chip, Vol. 17, Issue 22, pp. 3772-3784, (2018) (PubMed).
: "SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef." dans: Nature, Vol. 526, Issue 7572, pp. 218-23, (2016) (PubMed).
: "Intercellular adhesion molecule 1 promotes HIV-1 attachment but not fusion to target cells." dans: PLoS ONE, Vol. 7, Issue 9, pp. e44827, (2013) (PubMed).
: "The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein." dans: Retrovirology, Vol. 7, pp. 95, (2010) (PubMed).
: "Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120." dans: The Journal of general virology, Vol. 89, Issue Pt 10, pp. 2597-604, (2008) (PubMed).
: "HIV coreceptors: from discovery and designation to new paradigms and promise." dans: European journal of medical research, Vol. 12, Issue 9, pp. 375-84, (2007) (PubMed).
: "Roles of HIV-1 Env variable regions in viral neutralization and vaccine development." dans: Current HIV research, Vol. 5, Issue 6, pp. 542-53, (2007) (PubMed).